Identification of a Novel ALK G1123S Mutation in a Patient with ALK-rearranged Non-small-cell Lung Cancer Exhibiting Resistance to Ceritinib. [electronic resource]
Producer: 20160505Description: e55-7 p. digitalISSN:- 1556-1380
- Anaplastic Lymphoma Kinase
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Drug Resistance, Neoplasm
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Mutation
- Pyrimidines -- therapeutic use
- Receptor Protein-Tyrosine Kinases -- genetics
- Sulfones -- therapeutic use
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.